Age-related visual impairment is a prevalent condition that affects millions of people worldwide. With the aging...
PROSTAMAX - 50mg
119,00 €
The treatment of one of the most common urological diseases, a chronic aseptic prostatitis, is an exigeant problem. Used methods of pharmacotherapy are insufficiently effective and after treatment, as a rule, there comes a recrudescence. The new prostatotropic agent Prostamax is related to bioregulator peptides at experimental chronic aseptic inflammation of prostate gland. It is established that Prostamax reduces intensity of signs of a chronic inflammation, prevents development of sclerotic and atrophic processes and intensifies sexual activity of animals. Efficiency of the preparation Prostamax surpasses that among widespread prostatotropic agents derived from